← Back to Search

Cancer Prevention Education for Breast and Cervical Cancer (SEMM2 Trial)

N/A

Recruiting

Led By Lara Savas, PhD

Research Sponsored by The University of Texas Health Science Center, Houston

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up between baseline and end of study (about 9 months)

Awards & highlights

SEMM2 Trial Summary

This trial aims to reduce breast & cervical cancer in underserved Latinas through education, navigation, screening & HPV vaccination.

Who is the study for?

This trial is for Latina women in certain Texas counties who are over 40 with no mammogram in the last 2 years, aged 21-65 with no Pap test in the past 3 years, or aged 18-26 (up to age 45 if recommended) needing HPV vaccination. Pregnant women or those with a current/past cancer diagnosis cannot join.Check my eligibility

What is being tested?

The study aims to improve early detection and prevention of breast and cervical cancer among underserved Latinas through educational programs and helping them navigate healthcare services to get screened for cancer and receive HPV vaccinations.See study design

What are the potential side effects?

Since this trial focuses on education and navigation assistance rather than medical treatments, there are no direct side effects from interventions like drugs or surgery. However, participants may experience stress or anxiety related to screening procedures.

SEMM2 Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ between baseline and end of study (about 9 months)

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~between baseline and end of study (about 9 months)

This trial's timeline: 3 weeks for screening, Varies for treatment, and between baseline and end of study (about 9 months) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Number of women 18-26 years who initiate (complete first dose) of the HPV vaccine

Number of women 21-65 years who complete Pap test screening

Number of women 40 and older who complete mammogram screening

Secondary outcome measures

Number of women 18-26 years who receive dose 2 of HPV vaccine

Number of women 18-26 years who receive dose 3 of HPV vaccine

SEMM2 Trial Design

3Treatment groups

Experimental Treatment

Group I: Zoom Delivered Breast and Cervical Cancer Behavioral InterventionExperimental Treatment2 Interventions

Community health worker delivered behavioral education and referrals to low-cost services. Delivered by Zoom to individual participants. Participants are followed up by health coach navigators to address barriers and connect to safety-net clinics.

Group II: Telephone Delivered Breast and Cervical Cancer Behavioral InterventionExperimental Treatment2 Interventions

Community health worker delivered behavioral education and referrals to low-cost services. Delivered by telephone to individual participants. Participants are followed up by health coach navigators to address barriers and connect to safety-net clinics.

Group III: In-Person Delivered Breast and Cervical Cancer Behavioral InterventionExperimental Treatment2 Interventions

Community health worker delivered behavioral education and referrals to low-cost services. Delivered in person to participants in community and clinic settings. Participants are followed up by health coach navigators to address barriers and connect to safety-net clinics.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Education

2017

N/A

~4770

Navigation to clinic

2016

N/A

~8270

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

The University of Texas Health Science Center, HoustonLead Sponsor

904 Previous Clinical Trials

312,960 Total Patients Enrolled

10 Trials studying Breast Cancer

16,043 Patients Enrolled for Breast Cancer

Cancer Prevention Research Institute of TexasOTHER

50 Previous Clinical Trials

90,438 Total Patients Enrolled

7 Trials studying Breast Cancer

10,905 Patients Enrolled for Breast Cancer

Lara Savas, PhDPrincipal InvestigatorThe University of Texas Health Science Center, Houston

3 Previous Clinical Trials

10,770 Total Patients Enrolled

1 Trials studying Breast Cancer

8,262 Patients Enrolled for Breast Cancer

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is this experiment open to octogenarians?

"In accordance with the qualifications set forth for this clinical trial, individuals aged 18 and older up to 74 are eligible for enrollment."

Answered by AI

Am I eligible to partake in this investigation?

"Aspiring participants must have breast cancer and be aged 18-74 to join this trial. A total of 8,000 patients will eventually take part in the experiment."

Answered by AI

Is there still the capacity to enrol participants in this investigation?

"As of now, this medical trial is searching for volunteers. It was initially posted on the 20th of February 2020 and recently updated on October 9th 2021."

Answered by AI

To what degree is the research pool engaged in this exploration?

"Affirmative. Clinicaltrials.gov shows that this research study, which was initially posted on February 20th 2020, is currently recruiting patients to participate in the trial. A total of 8000 participants from one site are necessary for successful enrolment."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Salud en Mis Manos - Breast and Cervical Cancer Prevention and Early Detection - Expansion 2

Lara Savas 2020. "Salud en Mis Manos - Breast and Cervical Cancer Prevention and Early Detection - Expansion 2". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT06082882.

All > Cervical Cancer